1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Shoichi Maruyama MD PhD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome Rituximab (genetical recombination), Placebo - Glomerulonephritis, Membranous, Nephrotic Syndrome，Idiopathic | Phase 3 | Active not recruiting | Shoichi Maruyama MD PhD | 88 | 2023-06-24 | 2026-08-12 |
Glomerulonephritis, Membranous (1) · Nephrosis, Lipoid (1)
Rituximab (1)
Japan (1)